Axim Biotechnologies (AXIM) 0.9400 $AXIM
Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend
GlobeNewswire - Thu Jul 02, 11:09AM CDT
When signing the Clay Hunt Suicide Prevention for American Veterans Act, President Obama called on Americans to, "Reach out and do more with and for our veterans."
Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies
GlobeNewswire - Tue Jun 30, 8:30AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies (OTCBB:AXIM), a cutting-edge biotechnology innovator.
Photo Release -- AXIM Biotech Announces Hemp Innovations for Life Sciences
GlobeNewswire - Thu Jun 04, 8:00AM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products - all derived or related to hemp. The Company's core belief is responsibility for environmental stewardship combined with development of innovative products to address current conditions with no known effective treatment including: Parkinson's disease, Alzheimer's disease / dementia, ADHD (attention deficit hyperactivity disorder), PTSD, autism, MS, spasticity, pain, RLS (restless leg syndrome), glaucoma, IBD, IBS and Crohn's disease.
Photo Release -- Patent for World's First Cannabinoid Release Gum Awarded to Medical Marijuana, Inc.'s Joint Venture Partner -- CanChew Biotechnologies, LLC
GlobeNewswire - Wed May 27, 8:00AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is proud to announce that its joint venture partner, CanChew Biotechnologies, LLC (CanChew), was awarded the U.S. Patent for Chewing Gum Compositions Comprising Cannabinoids (United States Patent 9023322). The patent was also applied for in Europe, Canada Mexico, Japan, China, India, Australia, Singapore, among others.
Photo Release -- AXIM Biotech CEO Honored By Adopt-A-Soldier Platoon
GlobeNewswire - Tue May 26, 8:00AM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM), a leader in industrial hemp biosciences, is proud to announce that the Company was recently recognized by Adopt-A-Soldier Platoon, Inc. ("Adopt-A-Soldier Platoon"
, a Veterans-focused non-profit organization, for its service though philanthropy. AXIM Biotech selected Adopt-A-Soldier Platoon as a recipient of the Company's community outreach efforts in 2015.
Photo Release -- AXIM Biotech's New Website Commissioned to Award Winning Artist Andre Weinfeld
GlobeNewswire - Tue May 19, 8:00AM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM), a leader in industrial hemp biosciences, is proud to announce the launch of its new website at www.AXIMbiotech.com. The industrial hemp biotech's website is designed by Andre Weinfeld, a renowned Producer, Writer, Director, Journalist and Photographer.
Medical Marijuana Inc. Announces 2014 Annual Report and Shareholder Letter- Product Sales Increased 280+% Over Prior Year
GlobeNewswire - Thu May 14, 1:43PM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA), a leading cannabis and industrial hemp industry innovator, sources, evaluates and acquires value-added companies with a focus on the medicinal cannabis and industrial hemp industries. Today, the Company announced the release of its 2014 annual report and shareholders letter. The Company continued to have exceptional growth over the year with product sales total of over $14,522,892 compared to $5,059,924 for the prior year, representing a sales increase of more than 280%.
Photo Release -- AXIM Biotech Secures Exclusive License Agreement to Patented Cannabidiol (CBD) Gum
GlobeNewswire - Thu May 14, 1:01PM CDT
Industrial hemp biosciences industry leader, AXIM Biotechnologies, Inc. (OTC:AXIM), is proud to announce that the Company has successfully secured an exclusive license from CanChew Biotechnologies, LLC (CanChew), to further develop and produce CanChew gum, a unique, patented controlled-release cannabinoid-infused chewing gum.
Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines of Cannabigerol (CBG) Products
GlobeNewswire - Mon Apr 20, 2:12PM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM), is pleased to announce that the company's innovative new hemp-based cannabigerol (CBG) product lines were covered in global press after the Company revealed that it's actively developing a new retail market of everyday use products containing the "stem cell cannabinoid."
Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board
GlobeNewswire - Wed Mar 18, 11:31AM CDT
AXIM Biotechnologies (OTC:AXIM), an industrial hemp biosciences industry leader, welcomes Dr. Jacques F. Meis, MD, PhD, world-renowned infectious disease specialist, to the Company's medical advisory board.
AXIM Biotechnologies, Inc. Announces Cosmetics Division
GlobeNewswire - Thu Feb 19, 9:14AM CST
AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and industrial hemp product development, is proud to announce that it has plans to revitalize the cosmetics industry with the launch of its new hemp cannabinoid-based Cosmetics Division.
AXIM Biotechnologies, Inc. Announces Hemp-Based Oral Care Division
GlobeNewswire - Thu Feb 12, 10:33AM CST
AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and commercial hemp product development, is proud to announce that it is launching a hemp-based Oral Care Division.
Photo Release: Dr. Murad A. Sunalp, Internationally Recognized Ophthalmology Expert, Joins AXIM Biotechnologies Advisory Board
GlobeNewswire - Tue Jan 20, 8:15AM CST
AXIM Biotechnologies (OTC:AXIM) is actively recruiting top minds and experts in medicine. The Company is pleased to announce that Murad A. Sunalp M.D., B.M., B. Ch. MBA has joined AXIM Biotechnologies' Board of Advisors. Dr. Sunalp brings extensive knowledge of ophthalmology to the Company's industrial hemp-based pharmaceutical research and development projects.
Photo Release: AXIM Biotechnologies Adds World Leaders In Cannabis Research and International Finance to Advisory Board
GlobeNewswire - Thu Dec 11, 1:03PM CST
AXIM Biotechnologies (OTC:AXIM) is extremely proud to announce the newest appointments to the Company's Advisory Board: Dr. Arno Hazekamp, Ph.D., and Mr. Warren C. Hutchins. Their professional backgrounds will help AXIM Biotechnologies propel the re-emergence of industrial hemp-based consumer products into the global marketplace. Their respective global areas of expertise are in cannabinoid medical research and multi-cultural business development and international finance.
Photo Release: AXIM Biotechnologies Announces Netherlands Land Deal for Manufacturing Site
GlobeNewswire - Thu Nov 20, 4:17PM CST
AXIM Biotechnologies (OTC:AXIM) brings to market global innovative solutions that set the "green standard" in the industrial hemp industry. The Company selected the coastal city of Almere, The Netherlands, for its future manufacturing facility headquarters. AXIM Biotechnologies has executed an option agreement for a land purchase of a 5,328 m2 industrial parcel. In addition, the Company holds an agreement for design and feasibility services with a commercial real estate developer G&S Bouw based in Amsterdam, The Netherlands.
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
GlobeNewswire - Thu Nov 06, 8:45AM CST
AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's pharmaceutical pipeline and cannabinoid-based drug delivery platforms.
AXIM Biotechnologies Delivers Net Negative Carbon Footprint With All-Natural Industrial Hemp
GlobeNewswire - Thu Oct 30, 8:00AM CDT
AXIM Biotechnologies (OTC:AXIM) proudly announces its strategic focus: bring to market global innovative solutions that set the "green standard" in the industrial hemp industry.
Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend
GlobeNewswire - Thu Jul 02, 11:09AM CDT
When signing the Clay Hunt Suicide Prevention for American Veterans Act, President Obama called on Americans to, "Reach out and do more with and for our veterans."
Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies
GlobeNewswire - Tue Jun 30, 8:30AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies (OTCBB:AXIM), a cutting-edge biotechnology innovator.
Photo Release -- AXIM Biotech Announces Hemp Innovations for Life Sciences
GlobeNewswire - Thu Jun 04, 8:00AM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products - all derived or related to hemp. The Company's core belief is responsibility for environmental stewardship combined with development of innovative products to address current conditions with no known effective treatment including: Parkinson's disease, Alzheimer's disease / dementia, ADHD (attention deficit hyperactivity disorder), PTSD, autism, MS, spasticity, pain, RLS (restless leg syndrome), glaucoma, IBD, IBS and Crohn's disease.
Photo Release -- Patent for World's First Cannabinoid Release Gum Awarded to Medical Marijuana, Inc.'s Joint Venture Partner -- CanChew Biotechnologies, LLC
GlobeNewswire - Wed May 27, 8:00AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is proud to announce that its joint venture partner, CanChew Biotechnologies, LLC (CanChew), was awarded the U.S. Patent for Chewing Gum Compositions Comprising Cannabinoids (United States Patent 9023322). The patent was also applied for in Europe, Canada Mexico, Japan, China, India, Australia, Singapore, among others.
Photo Release -- AXIM Biotech CEO Honored By Adopt-A-Soldier Platoon
GlobeNewswire - Tue May 26, 8:00AM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM), a leader in industrial hemp biosciences, is proud to announce that the Company was recently recognized by Adopt-A-Soldier Platoon, Inc. ("Adopt-A-Soldier Platoon"
, a Veterans-focused non-profit organization, for its service though philanthropy. AXIM Biotech selected Adopt-A-Soldier Platoon as a recipient of the Company's community outreach efforts in 2015. Photo Release -- AXIM Biotech's New Website Commissioned to Award Winning Artist Andre Weinfeld
GlobeNewswire - Tue May 19, 8:00AM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM), a leader in industrial hemp biosciences, is proud to announce the launch of its new website at www.AXIMbiotech.com. The industrial hemp biotech's website is designed by Andre Weinfeld, a renowned Producer, Writer, Director, Journalist and Photographer.
Medical Marijuana Inc. Announces 2014 Annual Report and Shareholder Letter- Product Sales Increased 280+% Over Prior Year
GlobeNewswire - Thu May 14, 1:43PM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA), a leading cannabis and industrial hemp industry innovator, sources, evaluates and acquires value-added companies with a focus on the medicinal cannabis and industrial hemp industries. Today, the Company announced the release of its 2014 annual report and shareholders letter. The Company continued to have exceptional growth over the year with product sales total of over $14,522,892 compared to $5,059,924 for the prior year, representing a sales increase of more than 280%.
Photo Release -- AXIM Biotech Secures Exclusive License Agreement to Patented Cannabidiol (CBD) Gum
GlobeNewswire - Thu May 14, 1:01PM CDT
Industrial hemp biosciences industry leader, AXIM Biotechnologies, Inc. (OTC:AXIM), is proud to announce that the Company has successfully secured an exclusive license from CanChew Biotechnologies, LLC (CanChew), to further develop and produce CanChew gum, a unique, patented controlled-release cannabinoid-infused chewing gum.
Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines of Cannabigerol (CBG) Products
GlobeNewswire - Mon Apr 20, 2:12PM CDT
AXIM Biotechnologies, Inc. (OTC:AXIM), is pleased to announce that the company's innovative new hemp-based cannabigerol (CBG) product lines were covered in global press after the Company revealed that it's actively developing a new retail market of everyday use products containing the "stem cell cannabinoid."
Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board
GlobeNewswire - Wed Mar 18, 11:31AM CDT
AXIM Biotechnologies (OTC:AXIM), an industrial hemp biosciences industry leader, welcomes Dr. Jacques F. Meis, MD, PhD, world-renowned infectious disease specialist, to the Company's medical advisory board.
AXIM Biotechnologies, Inc. Announces Cosmetics Division
GlobeNewswire - Thu Feb 19, 9:14AM CST
AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and industrial hemp product development, is proud to announce that it has plans to revitalize the cosmetics industry with the launch of its new hemp cannabinoid-based Cosmetics Division.
AXIM Biotechnologies, Inc. Announces Hemp-Based Oral Care Division
GlobeNewswire - Thu Feb 12, 10:33AM CST
AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and commercial hemp product development, is proud to announce that it is launching a hemp-based Oral Care Division.
Photo Release: Dr. Murad A. Sunalp, Internationally Recognized Ophthalmology Expert, Joins AXIM Biotechnologies Advisory Board
GlobeNewswire - Tue Jan 20, 8:15AM CST
AXIM Biotechnologies (OTC:AXIM) is actively recruiting top minds and experts in medicine. The Company is pleased to announce that Murad A. Sunalp M.D., B.M., B. Ch. MBA has joined AXIM Biotechnologies' Board of Advisors. Dr. Sunalp brings extensive knowledge of ophthalmology to the Company's industrial hemp-based pharmaceutical research and development projects.
Photo Release: AXIM Biotechnologies Adds World Leaders In Cannabis Research and International Finance to Advisory Board
GlobeNewswire - Thu Dec 11, 1:03PM CST
AXIM Biotechnologies (OTC:AXIM) is extremely proud to announce the newest appointments to the Company's Advisory Board: Dr. Arno Hazekamp, Ph.D., and Mr. Warren C. Hutchins. Their professional backgrounds will help AXIM Biotechnologies propel the re-emergence of industrial hemp-based consumer products into the global marketplace. Their respective global areas of expertise are in cannabinoid medical research and multi-cultural business development and international finance.
Photo Release: AXIM Biotechnologies Announces Netherlands Land Deal for Manufacturing Site
GlobeNewswire - Thu Nov 20, 4:17PM CST
AXIM Biotechnologies (OTC:AXIM) brings to market global innovative solutions that set the "green standard" in the industrial hemp industry. The Company selected the coastal city of Almere, The Netherlands, for its future manufacturing facility headquarters. AXIM Biotechnologies has executed an option agreement for a land purchase of a 5,328 m2 industrial parcel. In addition, the Company holds an agreement for design and feasibility services with a commercial real estate developer G&S Bouw based in Amsterdam, The Netherlands.
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
GlobeNewswire - Thu Nov 06, 8:45AM CST
AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's pharmaceutical pipeline and cannabinoid-based drug delivery platforms.
AXIM Biotechnologies Delivers Net Negative Carbon Footprint With All-Natural Industrial Hemp
GlobeNewswire - Thu Oct 30, 8:00AM CDT
AXIM Biotechnologies (OTC:AXIM) proudly announces its strategic focus: bring to market global innovative solutions that set the "green standard" in the industrial hemp industry.
